Costa rica launches first national eczema treatment tracking system
NCT ID NCT07448363
Summary
This study creates a national registry to track how well advanced eczema treatments work for patients in Costa Rica. Researchers will follow 50 people with moderate-to-severe eczema who are already receiving treatments like dupilumab or JAK inhibitors as part of their regular care. The goal is to understand how these treatments affect patients' skin symptoms and quality of life over time in real-world settings.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Caja Costarricense del Seguro Social
San José, Provincia de San José, 40901, Costa Rica
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.